Yixintang Pharmaceutical Group Co., Ltd.

SZSE:002727 Voorraadrapport

Marktkapitalisatie: CN¥8.6b

Yixintang Pharmaceutical Group Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Yixintang Pharmaceutical Group's earnings have been declining at an average annual rate of -2.9%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 12.1% per year. Yixintang Pharmaceutical Group's return on equity is 2.2%, and it has net margins of 0.9%.

Belangrijke informatie

-2.9%

Groei van de winst

-3.9%

Groei van de winst per aandeel

Consumer Retailing Groei van de industrie12.8%
Inkomstengroei12.1%
Rendement op eigen vermogen2.2%
Nettomarge0.9%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

May 03
Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

Recent updates

Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings

Sep 25
Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings

These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Jul 15
These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well

Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital

Jun 29
Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital

Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price

Jun 13
Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price

Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower

Jun 13
Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower

Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40

May 27
Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40

Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

May 03
Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings

Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)

Apr 15
Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)

Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing

Mar 06
Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing

Opbrengsten en kosten

Hoe Yixintang Pharmaceutical Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:002727 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 2418,1571565,08911
30 Jun 2418,0103274,88711
31 Mar 2418,0445524,74111
31 Dec 2317,3805494,68410
30 Sep 2318,2191,0194,59313
30 Jun 2318,1421,0964,61512
31 Mar 2317,8721,0704,6179
01 Jan 2317,4321,0104,5929
30 Sep 2216,1158354,3765
30 Jun 2215,8518164,3703
31 Mar 2215,1548404,2674
01 Jan 2214,5879224,0905
30 Sep 2113,9169503,9994
30 Jun 2113,3298973,8224
31 Mar 2112,9988463,6233
31 Dec 2012,6567903,5441
30 Sep 2012,0567243,4661
30 Jun 2011,4486833,3781
31 Mar 2010,9786333,3580
31 Dec 1910,4796043,2450
30 Sep 1910,2195873,1500
30 Jun 199,9455663,0350
31 Mar 199,5855652,9230
01 Jan 199,1765212,8450
30 Sep 188,7685252,7400
30 Jun 188,3914992,6790
31 Mar 188,1164572,6120
31 Dec 177,7514232,4970
30 Sep 177,3163862,3360
30 Jun 176,9493732,2290
31 Mar 176,5843452,0920
31 Dec 166,2493532,0360
30 Sep 165,9713791,9970
30 Jun 165,7743691,9250
31 Mar 165,6003611,8870
31 Dec 155,3213461,7470
30 Sep 155,0803231,5970
30 Jun 154,8543141,4720
31 Mar 154,5893101,3900
31 Dec 144,4282971,3320
30 Sep 144,2362921,2970
30 Jun 143,9952791,2330
31 Mar 143,7922531,3920
31 Dec 133,5472411,0810

Kwaliteitswinsten: 002727 has a large one-off loss of CN¥92.9M impacting its last 12 months of financial results to 30th September, 2024.

Groeiende winstmarge: 002727's current net profit margins (0.9%) are lower than last year (5.6%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 002727's earnings have declined by 2.9% per year over the past 5 years.

Versnelling van de groei: 002727's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Winst versus industrie: 002727 had negative earnings growth (-84.7%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).


Rendement op eigen vermogen

Hoge ROE: 002727's Return on Equity (2.2%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden